Liquidia (NASDAQ:LQDA) CEO Roger Jeffs Sells 25,000 Shares

Liquidia Corporation (NASDAQ:LQDAGet Free Report) CEO Roger Jeffs sold 25,000 shares of Liquidia stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $61.13, for a total transaction of $1,528,250.00. Following the completion of the sale, the chief executive officer directly owned 1,098,095 shares in the company, valued at $67,126,547.35. This represents a 2.23% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Roger Jeffs also recently made the following trade(s):

  • On Tuesday, May 26th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $60.38, for a total transaction of $1,509,500.00.
  • On Tuesday, May 19th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $58.65, for a total transaction of $1,466,250.00.
  • On Friday, May 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $57.04, for a total transaction of $1,426,000.00.
  • On Wednesday, May 13th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $56.29, for a total transaction of $1,407,250.00.
  • On Monday, May 11th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $41.50, for a total transaction of $1,037,500.00.
  • On Thursday, May 7th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $42.09, for a total transaction of $1,052,250.00.
  • On Tuesday, May 5th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $40.10, for a total transaction of $1,002,500.00.
  • On Friday, April 17th, Roger Jeffs sold 18,839 shares of Liquidia stock. The shares were sold at an average price of $40.60, for a total transaction of $764,863.40.
  • On Wednesday, April 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $40.14, for a total transaction of $1,003,500.00.
  • On Tuesday, April 14th, Roger Jeffs sold 3,300 shares of Liquidia stock. The shares were sold at an average price of $40.00, for a total transaction of $132,000.00.

Liquidia Price Performance

Liquidia stock opened at $60.10 on Wednesday. The company’s fifty day moving average price is $43.00 and its 200 day moving average price is $37.80. Liquidia Corporation has a 1 year low of $11.85 and a 1 year high of $62.30. The stock has a market capitalization of $5.34 billion, a P/E ratio of 429.32 and a beta of 0.41. The company has a debt-to-equity ratio of 1.18, a quick ratio of 2.03 and a current ratio of 2.22.

Liquidia (NASDAQ:LQDAGet Free Report) last released its quarterly earnings results on Monday, May 11th. The company reported $0.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.41 by $0.11. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. The firm had revenue of $132.87 million for the quarter, compared to analysts’ expectations of $119.44 million. The company’s quarterly revenue was up 4187.1% compared to the same quarter last year. As a group, equities research analysts anticipate that Liquidia Corporation will post 2.97 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Northwestern Mutual Wealth Management Co. purchased a new position in shares of Liquidia during the 4th quarter worth $25,000. NewEdge Advisors LLC purchased a new position in shares of Liquidia during the 2nd quarter worth $25,000. Skandinaviska Enskilda Banken AB publ purchased a new position in shares of Liquidia during the 3rd quarter worth $30,000. FNY Investment Advisers LLC purchased a new position in shares of Liquidia during the 3rd quarter worth $34,000. Finally, Covestor Ltd raised its holdings in shares of Liquidia by 41.9% during the 4th quarter. Covestor Ltd now owns 1,216 shares of the company’s stock worth $42,000 after acquiring an additional 359 shares during the period. Hedge funds and other institutional investors own 64.54% of the company’s stock.

Wall Street Analyst Weigh In

LQDA has been the topic of a number of research reports. BTIG Research raised their price objective on Liquidia from $50.00 to $59.00 and gave the company a “buy” rating in a report on Monday, May 11th. Wall Street Zen upgraded Liquidia from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 16th. Jefferies Financial Group restated a “buy” rating and issued a $60.00 price objective on shares of Liquidia in a report on Monday, May 11th. Raymond James Financial restated a “strong-buy” rating on shares of Liquidia in a report on Thursday, March 5th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Liquidia in a report on Tuesday, April 21st. Three investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $49.33.

Get Our Latest Stock Report on LQDA

Liquidia Company Profile

(Get Free Report)

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINTĀ® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).

Recommended Stories

Insider Buying and Selling by Quarter for Liquidia (NASDAQ:LQDA)

Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with MarketBeat.com's FREE daily email newsletter.